Back to Search
Start Over
Dare Bioscience Announce Achievement of First Commercial Milestone Under License Agreement for XACIATOtm Vaginal Gel, 2%
- Source :
- Plus Company Updates. October 16, 2023
- Publication Year :
- 2023
-
Abstract
- SAN DIEGO: Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced the first shipment of XACIATOTM [pronounced zah-she-AH-toe] (clindamycin phosphate) vaginal gel, 2% in connection with [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.770616424